These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9815219)

  • 21. Conservation of outer membrane protein E among strains of Moraxella catarrhalis.
    Murphy TF; Brauer AL; Yuskiw N; McNamara ER; Kirkham C
    Infect Immun; 2001 Jun; 69(6):3576-80. PubMed ID: 11349016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
    Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
    Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival in vivo.
    Helminen ME; Maciver I; Paris M; Latimer JL; Lumbley SL; Cope LD; McCracken GH; Hansen EJ
    J Infect Dis; 1993 Nov; 168(5):1194-201. PubMed ID: 8228353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An aerosol challenge mouse model for Moraxella catarrhalis.
    Hu WG; Chen J; Collins FM; Gu XX
    Vaccine; 1999 Dec; 18(9-10):799-804. PubMed ID: 10580192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis.
    Hu WG; Chen J; McMichael JC; Gu XX
    Infect Immun; 2001 Mar; 69(3):1358-63. PubMed ID: 11179299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine.
    Jiao X; Hirano T; Hou Y; Gu XX
    Infect Immun; 2002 Nov; 70(11):5982-9. PubMed ID: 12379673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of an isogenic mutant constructed in Moraxella catarrhalis To identify a protective epitope of outer membrane protein B1 defined by monoclonal antibody 11C6.
    Luke NR; Russo TA; Luther N; Campagnari AA
    Infect Immun; 1999 Feb; 67(2):681-7. PubMed ID: 9916077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outer membrane protein CD of Branhamella catarrhalis: sequence conservation in strains recovered from the human respiratory tract.
    Hsiao CB; Sethi S; Murphy TF
    Microb Pathog; 1995 Oct; 19(4):215-25. PubMed ID: 8825909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum antibody response to proteins of Moraxella (Branhamella) catarrhalis in patients with lower respiratory tract infection.
    Christensen JJ; Renneberg J; Bruun B; Forsgren A
    Clin Diagn Lab Immunol; 1995 Jan; 2(1):14-7. PubMed ID: 7719906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a 74-kDa transferrin-binding protein from Moraxella (Branhamella) catarrhalis as a vaccine candidate.
    Chen D; McMichael JC; VanDerMeid KR; Masi AW; Bortell E; Caplan JD; Chakravarti DN; Barniak VL
    Vaccine; 1999 Aug; 18(1-2):109-18. PubMed ID: 10501241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response to surface protein A of Streptococcus pneumoniae and to high-molecular-weight outer membrane protein A of Moraxella catarrhalis in children with acute otitis media.
    Samukawa T; Yamanaka N; Hollingshead S; Murphy TF; Faden H
    J Infect Dis; 2000 May; 181(5):1842-5. PubMed ID: 10823798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoinformatics Identifies a Lactoferrin Binding Protein A Peptide as a Promising Vaccine With a Global Protective Prospective Against Moraxella catarrhalis.
    Yassin GM; Amin MA; Attia AS
    J Infect Dis; 2016 Jun; 213(12):1938-45. PubMed ID: 26908723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immunogenicity of the liposome-associated outer membrane proteins (OMPs) of Moraxella catarrhalis.
    Augustyniak D; Mleczko J; Gutowicz J
    Cell Mol Biol Lett; 2010; 15(1):70-89. PubMed ID: 19851720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new intra-NALT route elicits mucosal and systemic immunity against Moraxella catarrhalis in a mouse challenge model.
    Hou Y; Hu WG; Hirano T; Gu XX
    Vaccine; 2002 May; 20(17-18):2375-81. PubMed ID: 12009294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress toward the development of a vaccine to prevent Moraxella (Branhamella) catarrhalis infections.
    McMichael JC
    Microbes Infect; 2000 Apr; 2(5):561-8. PubMed ID: 10865201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human immune response to outer membrane protein CD of Moraxella catarrhalis in adults with chronic obstructive pulmonary disease.
    Murphy TF; Kirkham C; Liu DF; Sethi S
    Infect Immun; 2003 Mar; 71(3):1288-94. PubMed ID: 12595444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum antibody response to outer membrane proteins of Moraxella (Branhamella) catarrhalis in patients with bronchopulmonary infection.
    Christensen JJ; Hansen NQ; Bruun B
    Clin Diagn Lab Immunol; 1996 Nov; 3(6):717-21. PubMed ID: 8914764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis.
    Ruckdeschel EA; Brauer AL; Johnson A; Murphy TF
    Vaccine; 2009 Nov; 27(50):7065-72. PubMed ID: 19786139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Method for reducing endotoxin in Moraxella catarrhalis UspA2 protein preparations.
    Fiske MJ; Fredenburg RA; VanDerMeid KR; McMichael JC; Arumugham R
    J Chromatogr B Biomed Sci Appl; 2001 Apr; 753(2):269-78. PubMed ID: 11334340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum antibodies to outer membrane proteins (OMPs) of Moraxella (Branhamella) catarrhalis in patients with bronchiectasis: identification of OMP B1 as an important antigen.
    Sethi S; Hill SL; Murphy TF
    Infect Immun; 1995 Apr; 63(4):1516-20. PubMed ID: 7890418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.